Abstract
Guselkumab (Tremfya (TM)) is a human monoclonal IgG1 lambda antibody being developed by Janssen Biotech, Inc. that has been approved in the USA as a t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
